Project Grant R41NS122602
- This Project Grant from the National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, provides $920,176 under the Cardiovascular Diseases Research program to develop a smart aspiration catheter with fiber optic pressure sensors for mechanical thrombectomy procedures to treat acute ischemic stroke. The catheter will be designed, prototyped and validated at Worcester Polytechnic Institute to provide real-time data to interventionalists on the interaction...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $299,982 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Unandup, LLC, a technology development firm in St. Louis, Missouri. The grant funding supports the development of the Commercialization Readiness Pilot for the FAST (Flow Acceleration for Stroke Thrombolysis) System, an innovative medical device platform designed to safely accelerate the...
- This $1,199,991 Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program aims to develop novel technologies for real-time assessment of blood clot properties to improve stroke treatment. The key products and services under this grant include: Integration of a sub-millimeter Raman fiber probe into a catheter for intravascular, in-vivo measurement of clot chemical composition. Training of a convolutional neural network to...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant of $275,000 awarded to Xtract Medical Inc. aims to develop and demonstrate the feasibility of a novel catheter-based system for improved removal of blood clots during mechanical thrombectomy procedures to treat venous thromboembolism (VTE). The proposed system is designed to effectively remove large blood clots while minimizing damage to blood vessels and reducing complications such as...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $1,150,417 to Gentibio, Inc. to develop a novel allogeneic engineered tissue regulatory T cell (EngrTreg) therapy for the treatment of acute ischemic stroke. The key products or services to be delivered include: Development of an "off-the-shelf" EngrTreg therapy that leverages...
- This $490,049 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research by Shearit LLC to evaluate the efficacy of their Lamiflo drug for reducing ischemic penumbra and core volumes in acute ischemic stroke. The 1-year study will test Lamiflo, a drag-reducing polymer that enhances blood flow, in rat models of middle cerebral artery...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA Program 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders provides $227,475 in funding to the University of California, Davis for a 5-year study led by Dr. Kevin Keenan on prehospital diagnostic testing for large vessel occlusion (LVO) stroke triage. The study aims to develop and validate a new stroke screening test called CLEAR-LVO that combines...
- This federal Project Grant award of $598,636, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), supports the development of the EMULAATE platform by Spheric Bio Inc. The EMULAATE technology aims to address the mismatch between standard left atrial appendage occlusion (LAAO) devices and patient anatomy by enabling the assembly of personalized, soft implants directly inside the patient's body through a minimally-invasive procedure. This could...
- This federal Project Grant award from the National Center for Advancing Translational Sciences (NCATS), with CFDA Number 93.350, supports the development of a novel method for quantitative flow assessment within the treated artery during catheter embolization procedures. The $144,345 award will fund research to integrate electrochemical impedance spectroscopy (EIS) sensors into catheters for real-time monitoring of embolization, which can provide a more accurate evaluation of the embolization...
- The National Heart, Lung, and Blood Institute, through the Cardiovascular Diseases Research federal grant program (CFDA 93.837), awarded Smartairway LLC a $313,365 project grant on August 1, 2025 to develop a novel articulating stylet device for improving first-pass endotracheal intubation success rates. The proposed SmartStylet device can flex the endotracheal tube 60 degrees anteriorly and 15 degrees posteriorly while in the patient's airway, allowing real-time adjustments to match the...
ENABLING RAPID AND EFFECTIVE STROKE THROMBECTOMY PROCEDURES FROM A TRANSRADIAL APPROACH: COMBINING INTRODUCER SHEATH, GUIDE CATHETER, AND DISTAL ACCESS CATHETER INTO A SINGLE DEVICE. - PROJECT SUMMARY/ABSTRACT THIS PROPOSAL'S LONG-TERM GOAL IS TO IMPROVE THE CARE OF PATIENTS SUFFERING FROM LARGE VESSEL OCCLUSION ACUTE ISCHEMIC STROKE (LVO AIS). EMERGENT, CATHETER-BASED THROMBECTOMY IS AN ESTABLISHED TREATMENT FOR LVO AIS. STILL, SUBSTANTIAL LIMITATIONS REMAIN. RAPID CATHETERIZATION OF DISTAL, INTRACRANIAL VESSELS REPRESENTS AN ESSENTIAL FEATURE OF SUCCESSFUL THROMBECTOMY PROCEDURES. GIVEN THE ADVANCED AGE OF MANY OR MOST THROMBECTOMY CANDIDATES, HIGHLY TORTUOUS VESSELS ARE FREQUENTLY ENCOUNTERED WHEN TRAVERSING FROM THE FEMORAL TO CAROTID TERRITORIES. IT HAS BEEN SHOWN THAT SUBSTANTIAL TORTUOSITY LEADS TO WORSE OUTCOMES IN TRANSFEMORAL THROMBECTOMY PROCEDURES. THUS, MANY LEADING INTERVENTIONALISTS HAVE PROPOSED TRANSRADIAL ACCESS (TRA) IN PLACE OF TRANSFEMORAL ACCESS. WITHIN INTERVENTIONAL CARDIOLOGY, TRA IS THE PREFERRED ACCESS SITE FOR THE VAST MAJORITY OF PATIENTS, GIVEN LOW RATES OF BLEEDING COMPLICATIONS AND READY ACCESS TO THE CORONARY CIRCULATION. THE RADIAL SITE ALSO PROVIDES READY ACCESS TO THE CEREBRAL VASCULATURE, BYPASSING TORTUOSITY ALONG THE AORTIC ARCH, DESCENDING AORTA, AND ILIO-FEMORAL SYSTEM. MANY NEUROINTERVENTIONALISTS HAVE EMBRACED TRA FOR DIAGNOSTIC PROCEDURES. HOWEVER, EVEN THOUGH TRA WOULD PROVIDE SUBSTANTIALLY EASIER ACCESS THAN TRANSFEMORAL ACCESS FOR THROMBECTOMY PROCEDURES IN PATIENTS WITH SUBSTANTIAL TORTUOSITY, FEW PRACTITIONERS USE TRA FOR TREATMENT FOR THESE PATIENTS. THE PRIMARY IMPEDIMENT TO EXPANSION OF TRA THROMBECTOMY RELATES TO AN ONGOING DEARTH OF RADIAL-SPECIFIC ACCESS AND INTERVENTIONAL TOOLS, WHICH MUST BE CUSTOMIZED TO THE SMALL DIAMETER OF THE RADIAL ARTERY AS WELL AS THE SPECIFIC GEOMETRIC CHALLENGES IN NAVIGATING FROM THE SUBCLAVIAN TO CAROTID TERRITORIES. IN THIS PHASE 1 STTR PROGRAM, WE WILL DEVELOP AND TEST A NOVEL LARGE-BORE THROMBECTOMY SYSTEM APPROPRIATE FOR TRA. SPECIFICALLY, OUR WRIST-TO-BRAIN THROMBECTOMY SYSTEM IS A 3-IN-1 DEVICE THAT COMBINES ACCESS SHEATH, GUIDING CATHETER, AND DISTAL ACCESS CATHETER IN TO A SINGLE DEVICE. THIS INNOVATION WILL REQUIRE SPECIFIC ADVANCES IN DIRECT ARTERIAL ACCESS, KINK RESISTANCE, AND DISTAL SUPPLENESS. IF SUCCESSFUL, OUR W2B THROMBECTOMY SYSTEM WILL ENHANCE CARE OF ELDERLY PATIENTS WITH HIGHLY TORTUOUS VASCULATURE WHO PRESENT WITH LVO AIS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | ($11k) | 8/12/24 | ||
| Not listed | $0 | 10/20/21 | ||
| Not listed | $0 | 10/20/21 | ||
| Not listed | $490.1k | 9/10/21 | ||
| Not listed | $490.1k | 9/10/21 |